Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-5129 in Type 2 Diabetes Mellitus
NCT00335712Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing ONO-5129 Arm with Placebo Arm (2 arms). Primary endpoint: Fasting Blood Glucose at 8 weeks. Started Jun 2006; status: completed.
02
Drugs
ONO-5129
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00335712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335712.